We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This statistical bulletin presents a summary of mefloquine prescribing following the introduction of a new policy in September 2016.
This consultation (ARM83) welcomes views on proposals to classify Pirinase Hayfever Relief for Adults 0.05% Nasal Spray as a general sales list (GSL) product in the UK.
Requirements for Specific Marketing Authorisation Applications.
Enhanced case protocol for close contacts of patients with Panton-Valentine Leukocidin (PVL)-Staphylococcus aureus lower respiratory tract infections (LRTI).
Statistics on mefloquine prescribing in the UK armed forces.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).